Investing.com - Quotient Ltd reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Quotient Ltd announced earnings per share of $-10.810 on revenue of $8.86M. Analysts polled by Investing.com EPS of $-9.400 on revenue of $9.91M.
Quotient Ltd 's are down 98% and is trading at $1.500 , still down 98.66% from its 52 week high of $112.00 set on Tuesday, December 21, 2021.
Quotient Ltd follows other major Healthcare sector earnings this month
Quotient Ltd's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, EPS of $1.91 on revenue of $6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.78 on revenue of $22.6B, for EPS of $1.44 on revenue of $21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar